Afternoon Bakey , that would prove a bit difficult as 420 of us own near 85% of the company already , most I know in the Top 50 have purchased recently ..
Many Holders are the same SH that topped up to the gunnels @2.5c .... also as you are fact based ,, get back to us on how many shares Management have sold,,,, ?
Also as you are facts based , please tell us how many ASX Biotechs have an Option with a Fortune 500 Company for the Global Manufacturing of a First in Class Medicine?
so you must bve aware that MPL has a 19 yesr safety history , The info was supplied to PAA directly from VM to assist with applications for the K9 Trial and the Human Trial...
Could i suggest if you are facts based you may wish to stick solely to the ASX Highly Regulated Announcements and not lower yourself to have to pick through the comments on a Free Forum of like minded individuals that enjoy some banter ,,, while Scientific Progress and Advancements are being completed...
Best of luck with your investments ,,
- Forums
- ASX - By Stock
- PAA
- PharmAust - The Saviour of Global Populations?
PharmAust - The Saviour of Global Populations?, page-38
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
17.0¢ |
Change
-0.005(2.86%) |
Mkt cap ! $82.69M |
Open | High | Low | Value | Volume |
17.5¢ | 18.0¢ | 17.0¢ | $55.34K | 315.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 537417 | 17.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.5¢ | 88847 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 537417 | 0.170 |
6 | 211059 | 0.165 |
8 | 396304 | 0.160 |
6 | 336734 | 0.155 |
8 | 227993 | 0.150 |
Price($) | Vol. | No. |
---|---|---|
0.175 | 88847 | 4 |
0.180 | 185345 | 3 |
0.185 | 427553 | 5 |
0.190 | 835215 | 8 |
0.195 | 575777 | 10 |
Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |